联邦合格健康中心的药剂师为2型糖尿病患者提供药物治疗管理服务。
Provision of Medication Therapy Management by Pharmacists to Patients With Type-2 Diabetes Mellitus in a Federally Qualified Health Center.
作者信息
Ndefo Uche Anadu, Moultry Aisha Morris, Davis Portia N, Askew Raven
出版信息
P T. 2017 Oct;42(10):632-637.
BACKGROUND
Type-2 diabetes mellitus is a complex condition for which pharmacists are well suited to improve patient outcomes by delivering medication therapy management (MTM) services. When diabetes is well controlled, patients can avoid its long-term complications, such as cardiovascular and renal diseases. This article describes an MTM pilot program that was implemented at a federally qualified health center (FQHC).
METHODS
This program was implemented at three clinics involving patients with uncontrolled diabetes, defined as hemoglobin A1c (HbA) greater than 8%. The primary endpoint assessed was HbA. Secondary endpoints included knowledge scores, medication adherence, and patient satisfaction. Outcomes were compared with a group of patients from the same clinics who did not receive MTM.
RESULTS
Fifty-seven patients met the established criteria and were enrolled in the six-month program. Thirty-seven patients completed the program and had an average 15% reduction in HbA ( < 0.05). Their average knowledge scores and medication adherence scores also increased from baseline.
CONCLUSION
MTM provided by pharmacists as part of a health care team at an FQHC led to significant reductions in HbA.
背景
2型糖尿病是一种复杂的病症，药剂师非常适合通过提供药物治疗管理（MTM）服务来改善患者的治疗效果。当糖尿病得到良好控制时，患者可以避免其长期并发症，如心血管疾病和肾脏疾病。本文描述了在一家联邦合格健康中心（FQHC）实施的一项MTM试点项目。
方法
该项目在三家诊所实施，涉及糖化血红蛋白（HbA）大于8%的未得到控制的糖尿病患者。评估的主要终点是HbA。次要终点包括知识得分、药物依从性和患者满意度。将结果与来自同一诊所未接受MTM的一组患者进行比较。
结果
57名患者符合既定标准并参加了为期六个月的项目。37名患者完成了该项目，HbA平均降低了15%（<0.05）。他们的平均知识得分和药物依从性得分也较基线有所提高。
结论
在FQHC，药剂师作为医疗团队的一部分提供的MTM导致HbA显著降低。
Zotero 插件